The TELE-DD project on treatment nonadherence in the population with type 2 diabetes and comorbid depression

Abstract Diabetic patients have increased depression rates, diminished quality of life, and higher death rates due to depression comorbidity or diabetes complications. Treatment adherence (TA) and the maintenance of an adequate and competent self-care are crucial factors to reach optimal glycaemic c...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Juan Francisco Roy, María Luisa Lozano del Hoyo, Fernando Urcola-Pardo, Alicia Monreal-Bartolomé, Diana Cecilia Gracia Ruiz, María Mercedes Gómez Borao, Ana Belén Artigas Alcázar, José Pedro Martínez Casbas, Alexandra Aceituno Casas, María Teresa Andaluz Funcia, Javier García-Campayo, María Teresa Fernández Rodrigo
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/3870d7ecd3fc48dbb1b87c8818f2601b
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:3870d7ecd3fc48dbb1b87c8818f2601b
record_format dspace
spelling oai:doaj.org-article:3870d7ecd3fc48dbb1b87c8818f2601b2021-12-02T16:56:10ZThe TELE-DD project on treatment nonadherence in the population with type 2 diabetes and comorbid depression10.1038/s41598-021-87410-92045-2322https://doaj.org/article/3870d7ecd3fc48dbb1b87c8818f2601b2021-04-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-87410-9https://doaj.org/toc/2045-2322Abstract Diabetic patients have increased depression rates, diminished quality of life, and higher death rates due to depression comorbidity or diabetes complications. Treatment adherence (TA) and the maintenance of an adequate and competent self-care are crucial factors to reach optimal glycaemic control and stable quality of life in these patients. In this report, we present the baseline population analyses in phase I of the TELE-DD project, a three-phased population-based study in 23 Health Centres from the Aragonian Health Service Sector II in Zaragoza, Spain. The objectives of the present report are: (1) to determine the point prevalence of T2D and clinical depression comorbidity and treatment nonadherence; (2) to test if HbA1c and LDL-C, as primary DM outcomes, are related to TA in this population; and (3) to test if these DM primary outcomes are associated with TA independently of shared risk factors for DM and depression, and patients’ health behaviours. A population of 7,271 patients with type-2 diabetes and comorbid clinical depression was investigated for inclusion. Individuals with confirmed diagnoses and drug treatment for both illnesses (n = 3340) were included in the current phase I. A point prevalence of 1.9% was found for the T2D-depression comorbidity. The prevalence of patients nonadherent to treatment for these diseases was 35.4%. Multivariate analyses confirmed that lower diabetes duration, increased yearly PCS visits, HbA1c and LDL-C levels were independently related to treatment nonadherence. These findings informed the development of a telephonic monitoring platform for treatment of nonadherence for people with diabetes and comorbid depression and further trial, cost-effectiveness, and prognostic studies (phases II and III).Juan Francisco RoyMaría Luisa Lozano del HoyoFernando Urcola-PardoAlicia Monreal-BartoloméDiana Cecilia Gracia RuizMaría Mercedes Gómez BoraoAna Belén Artigas AlcázarJosé Pedro Martínez CasbasAlexandra Aceituno CasasMaría Teresa Andaluz FunciaJavier García-CampayoMaría Teresa Fernández RodrigoNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Juan Francisco Roy
María Luisa Lozano del Hoyo
Fernando Urcola-Pardo
Alicia Monreal-Bartolomé
Diana Cecilia Gracia Ruiz
María Mercedes Gómez Borao
Ana Belén Artigas Alcázar
José Pedro Martínez Casbas
Alexandra Aceituno Casas
María Teresa Andaluz Funcia
Javier García-Campayo
María Teresa Fernández Rodrigo
The TELE-DD project on treatment nonadherence in the population with type 2 diabetes and comorbid depression
description Abstract Diabetic patients have increased depression rates, diminished quality of life, and higher death rates due to depression comorbidity or diabetes complications. Treatment adherence (TA) and the maintenance of an adequate and competent self-care are crucial factors to reach optimal glycaemic control and stable quality of life in these patients. In this report, we present the baseline population analyses in phase I of the TELE-DD project, a three-phased population-based study in 23 Health Centres from the Aragonian Health Service Sector II in Zaragoza, Spain. The objectives of the present report are: (1) to determine the point prevalence of T2D and clinical depression comorbidity and treatment nonadherence; (2) to test if HbA1c and LDL-C, as primary DM outcomes, are related to TA in this population; and (3) to test if these DM primary outcomes are associated with TA independently of shared risk factors for DM and depression, and patients’ health behaviours. A population of 7,271 patients with type-2 diabetes and comorbid clinical depression was investigated for inclusion. Individuals with confirmed diagnoses and drug treatment for both illnesses (n = 3340) were included in the current phase I. A point prevalence of 1.9% was found for the T2D-depression comorbidity. The prevalence of patients nonadherent to treatment for these diseases was 35.4%. Multivariate analyses confirmed that lower diabetes duration, increased yearly PCS visits, HbA1c and LDL-C levels were independently related to treatment nonadherence. These findings informed the development of a telephonic monitoring platform for treatment of nonadherence for people with diabetes and comorbid depression and further trial, cost-effectiveness, and prognostic studies (phases II and III).
format article
author Juan Francisco Roy
María Luisa Lozano del Hoyo
Fernando Urcola-Pardo
Alicia Monreal-Bartolomé
Diana Cecilia Gracia Ruiz
María Mercedes Gómez Borao
Ana Belén Artigas Alcázar
José Pedro Martínez Casbas
Alexandra Aceituno Casas
María Teresa Andaluz Funcia
Javier García-Campayo
María Teresa Fernández Rodrigo
author_facet Juan Francisco Roy
María Luisa Lozano del Hoyo
Fernando Urcola-Pardo
Alicia Monreal-Bartolomé
Diana Cecilia Gracia Ruiz
María Mercedes Gómez Borao
Ana Belén Artigas Alcázar
José Pedro Martínez Casbas
Alexandra Aceituno Casas
María Teresa Andaluz Funcia
Javier García-Campayo
María Teresa Fernández Rodrigo
author_sort Juan Francisco Roy
title The TELE-DD project on treatment nonadherence in the population with type 2 diabetes and comorbid depression
title_short The TELE-DD project on treatment nonadherence in the population with type 2 diabetes and comorbid depression
title_full The TELE-DD project on treatment nonadherence in the population with type 2 diabetes and comorbid depression
title_fullStr The TELE-DD project on treatment nonadherence in the population with type 2 diabetes and comorbid depression
title_full_unstemmed The TELE-DD project on treatment nonadherence in the population with type 2 diabetes and comorbid depression
title_sort tele-dd project on treatment nonadherence in the population with type 2 diabetes and comorbid depression
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/3870d7ecd3fc48dbb1b87c8818f2601b
work_keys_str_mv AT juanfranciscoroy theteleddprojectontreatmentnonadherenceinthepopulationwithtype2diabetesandcomorbiddepression
AT marialuisalozanodelhoyo theteleddprojectontreatmentnonadherenceinthepopulationwithtype2diabetesandcomorbiddepression
AT fernandourcolapardo theteleddprojectontreatmentnonadherenceinthepopulationwithtype2diabetesandcomorbiddepression
AT aliciamonrealbartolome theteleddprojectontreatmentnonadherenceinthepopulationwithtype2diabetesandcomorbiddepression
AT dianaceciliagraciaruiz theteleddprojectontreatmentnonadherenceinthepopulationwithtype2diabetesandcomorbiddepression
AT mariamercedesgomezborao theteleddprojectontreatmentnonadherenceinthepopulationwithtype2diabetesandcomorbiddepression
AT anabelenartigasalcazar theteleddprojectontreatmentnonadherenceinthepopulationwithtype2diabetesandcomorbiddepression
AT josepedromartinezcasbas theteleddprojectontreatmentnonadherenceinthepopulationwithtype2diabetesandcomorbiddepression
AT alexandraaceitunocasas theteleddprojectontreatmentnonadherenceinthepopulationwithtype2diabetesandcomorbiddepression
AT mariateresaandaluzfuncia theteleddprojectontreatmentnonadherenceinthepopulationwithtype2diabetesandcomorbiddepression
AT javiergarciacampayo theteleddprojectontreatmentnonadherenceinthepopulationwithtype2diabetesandcomorbiddepression
AT mariateresafernandezrodrigo theteleddprojectontreatmentnonadherenceinthepopulationwithtype2diabetesandcomorbiddepression
AT juanfranciscoroy teleddprojectontreatmentnonadherenceinthepopulationwithtype2diabetesandcomorbiddepression
AT marialuisalozanodelhoyo teleddprojectontreatmentnonadherenceinthepopulationwithtype2diabetesandcomorbiddepression
AT fernandourcolapardo teleddprojectontreatmentnonadherenceinthepopulationwithtype2diabetesandcomorbiddepression
AT aliciamonrealbartolome teleddprojectontreatmentnonadherenceinthepopulationwithtype2diabetesandcomorbiddepression
AT dianaceciliagraciaruiz teleddprojectontreatmentnonadherenceinthepopulationwithtype2diabetesandcomorbiddepression
AT mariamercedesgomezborao teleddprojectontreatmentnonadherenceinthepopulationwithtype2diabetesandcomorbiddepression
AT anabelenartigasalcazar teleddprojectontreatmentnonadherenceinthepopulationwithtype2diabetesandcomorbiddepression
AT josepedromartinezcasbas teleddprojectontreatmentnonadherenceinthepopulationwithtype2diabetesandcomorbiddepression
AT alexandraaceitunocasas teleddprojectontreatmentnonadherenceinthepopulationwithtype2diabetesandcomorbiddepression
AT mariateresaandaluzfuncia teleddprojectontreatmentnonadherenceinthepopulationwithtype2diabetesandcomorbiddepression
AT javiergarciacampayo teleddprojectontreatmentnonadherenceinthepopulationwithtype2diabetesandcomorbiddepression
AT mariateresafernandezrodrigo teleddprojectontreatmentnonadherenceinthepopulationwithtype2diabetesandcomorbiddepression
_version_ 1718382793191325696